ALX ONCOLOGY HOLDINGS INC (ALXO) › Operating IncomeALX ONCOLOGY HOLDINGS INC (ALXO) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2018: -$13.68M2019: -$19.18M2020: -$43.66M2021: -$83.56M2022: -$127.44M2023: -$170.28M2024: -$142.47M2025: -$104.02M-$104.02M2018Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$104.02M+27.0%2024-$142.47M+16.3%2023-$170.28M-33.6%2022-$127.44M-52.5%2021-$83.56M-91.4%2020-$43.66M-127.6%2019-$19.18M-40.2%2018-$13.68M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share